ATLASATLAS fair value
ATLAS has no fair value for this stock today.
ALTEOGEN (196170.KQ)
ALTEOGEN stock price today, ATLAS forecast and fair value
Healthcare · Biotechnology · KOSDAQ · South Korea
₩218,500▲ 0.00%
Prices as of Oct 27, 2026 · KRW
Chance of rising in 1 month
47%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on ALTEOGEN in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On ALTEOGEN
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives ALTEOGEN a 47% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between ₩191,347 and ₩242,633; in 9 out of 10, between ₩155,026 and ₩299,481. Estimated annual volatility is 68%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- ₩14.7T
- Market cap (USD)
- $11.0B
- P/E ratio
- 77.6
- Dividend yield
- 0.12%
- 52-week high
- ₩569,000
- 52-week low
- ₩209,000
- Revenue (12 months)
- ₩254B
- Gross margin
- 80.9%
- Operating margin
- 49.6%
- Net margin
- 75.5%
- Beta
- 0.98
What this means
ATLAS does not publish a fair value for 196170.KQ right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks 196170.KQ has traded between ₩209,000 and ₩569,000. Today it is 61.6% below that high and 5% above its low.
On the business: net margin is 75.5%; it trades at 77.6 times earnings.
Its beta is 0.98: it moves roughly in line with the market.
About the company
ALTEOGEN Inc., a bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.
Want to see everything about ALTEOGEN?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What does ALTEOGEN do?
ALTEOGEN Inc., a bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.
What is the chance 196170.KQ goes up next month?
47%: close to a coin flip. In half of the simulated outcomes, 196170.KQ ends the month between ₩191,347 and ₩242,633.
How big is ALTEOGEN and what is its P/E ratio?
ALTEOGEN's market capitalization is ₩14.7T. Its price-to-earnings (P/E) ratio is 77.6: you pay ₩77.6 for each ₩1.00 of yearly earnings.
Does ALTEOGEN pay a dividend?
Yes. 196170.KQ's current dividend yield is 0.12% at today's price (₩218,500).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer